Boris Weiss, CEO of Medicare Pharmaceuticals, provides a brief overview of the difficulties to start clinical trials in Canada and his proposed pilot program to alleviate some of those difficulties.
Read More
Boris Weiss, CEO of Medipure Pharmaceuticals recently talked to us about the numerous clinical trials his company has in development throughout the world, including studies in Canada, United States, India, and Croatia.
Read More
Boris Weiss, Chief Executive Officer of Medicare Pharmaceuticals, and a leader in the biotech revolution currently underway in Canada, at the company’s headquarters in North Vancouver.
Read More
